This, like my last post, is essentially a pitch for an ineligible stock.
ALIM (Alimera Sciences) went public in April, 2010 at $11.00 It has gone through the inevitable bad phase of the IPO process and was below $2 for a while. It now looks on the charts to be bottoming out and finviz.com tells me that insiders have been accumulating shares for the last 6 months.
Will it get back above it's IPO price? It might. The insider activity says to me hat it's time to cover shorts and/or end "Underperform" picks in spite of the lousy TTM return numbers.